81 – 90 of 260
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Adherence to beta-blockers and long-term risk of heart failure and mortality after a myocardial infarction
(
- Contribution to journal › Article
-
Mark
Microvesicle signaling in cardiovascular biology under normal and pathobiological conditions
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Ligand-independent G protein-coupled estrogen receptor/G protein-coupled receptor 30 activity : Lack of receptor-dependent effects of G-1 and 17b-estradiol
(
- Contribution to journal › Article
-
Mark
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II) : a prospective natural history study
(
- Contribution to journal › Article
-
Mark
Hypothermia versus normothermia after out-of-hospital cardiac arrest
(
- Contribution to journal › Article
-
Mark
Registry-based randomized clinical trials in cardiology : Opportunities and challenges
(
- Contribution to journal › Scientific review
-
Mark
CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE) : Checklist with explanation and elaboration
(
- Contribution to journal › Article
-
Mark
Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE)
(
- Contribution to journal › Article
-
Mark
Effects of Bilberry and Oat intake on lipids, inflammation and exercise capacity after Acute Myocardial Infarction (BIOAMI) : study protocol for a randomized, double-blind, placebo-controlled trial
(
- Contribution to journal › Article